Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity

Janne Prawitt, Mouaadh Abdelkarim, Johanna H.M. Stroeve, Iuliana Popescu, Helene Duez, Vidya Velagapudi, Julie Dumont, Emmanuel Bouchaert, Theo H. van Dijk, Anthony Lucas, Emilie Dorchies, Mehdi Daoudi, Sophia Lestavel, Frank J. Gonzalez, Matej Orešič, Bertrand Cariou, Folkert Kuipers, Sandrine Caron, Bert Staels (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

156 Citations (Scopus)

Abstract

OBJECTIVE Bile acids (BA) participate in the maintenance of metabolic homeostasis acting through different signaling pathways. The nuclear BA receptor farnesoid X receptor (FXR) regulates pathways in BA, lipid, glucose, and energy metabolism, which become dysregulated in obesity. However, the role of FXR in obesity and associated complications, such as dyslipidemia and insulin resistance, has not been directly assessed.

RESEARCH DESIGN AND METHODS Here, we evaluate the consequences of FXR deficiency on body weight development, lipid metabolism, and insulin resistance in murine models of genetic and diet-induced obesity.

RESULTS FXR deficiency attenuated body weight gain and reduced adipose tissue mass in both models. Surprisingly, glucose homeostasis improved as a result of an enhanced glucose clearance and adipose tissue insulin sensitivity. In contrast, hepatic insulin sensitivity did not change, and liver steatosis aggravated as a result of the repression of β-oxidation genes. In agreement, liver-specific FXR deficiency did not protect from diet-induced obesity and insulin resistance, indicating a role for nonhepatic FXR in the control of glucose homeostasis in obesity. Decreasing elevated plasma BA concentrations in obese FXR-deficient mice by administration of the BA sequestrant colesevelam improved glucose homeostasis in a FXR-dependent manner, indicating that the observed improvements by FXR deficiency are not a result of indirect effects of altered BA metabolism.

CONCLUSIONS Overall, FXR deficiency in obesity beneficially affects body weight development and glucose homeostasis.
Original languageEnglish
Pages (from-to)1861-1871
JournalDiabetes
Volume60
Issue number7
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

    Fingerprint

Cite this

Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I., Duez, H., Velagapudi, V., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., Dorchies, E., Daoudi, M., Lestavel, S., Gonzalez, F. J., Orešič, M., Cariou, B., Kuipers, F., Caron, S., & Staels, B. (2011). Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes, 60(7), 1861-1871. https://doi.org/10.2337/db11-0030